Brief: Sihuan Pharma's Unit Completes Strategic Equity Investment In Canton Biologics
08/10/2026 17:11
BRIEF-Sihuan Pharma's Unit Completes Strategic Equity Investment In Canton Biologics Oct 8 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd 0460.HK:
UNIT COMPLETES STRATEGIC EQUITY INVESTMENT IN CANTON BIOLOGICS
UNIT AND CANTON BIOLOGICS PLAN JOINT COMMERCIALIZATION OF COLLAGEN PROTEIN
Further company coverage: 0460.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sihuan Pharmaceutical Holdings
See all newsBrief: Sihuan Pharma Says Products Developed By Unit Approved For Market Launch In Hong Kong
Brief: Sihuan Pharma's Unit Completes Strategic Equity Investment In Canton Biologics
Sihuan gains as Dongyan Skin Booster's new specifications approved for launch
Brief: Sihuan Pharma Says New Specifications Of Dongyan Skin Booster Approved For Launch By NMPA
Sihuan Pharmaceutical H1 profit jumps on medical aesthetics unit strength